MKS Instruments (MKSI) PT Lowered to $150 at TD Cowen

TD Cowen analyst Krish Sankar lowered the price target on MKS Instruments (NASDAQ: MKSI) to $150.00 (from $160.00) while maintaining a Buy rating.

The analyst commented: "Impressive June '24 quarter results and Sep Q/C2H24 outlook are symptomatic of the industry trends. Fundamentals have stabilized, and we highlight disciplined cost management, debt reduction, strength in the chemistries business and a strategic photonics win amid the doldrums of NAND spending. We like the set up of the stock into CY25."

You May Also Be Interested In

• Oruka Therapeutics (ORKA) PT Raised to $130 at UBS as Stock Undervalued
• SLB (SLB) PT Lowered to $62 at TD Cowen
• EOG Resources (EOG) PT Lowered to $134 at Truist Securities